Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis., Shimizu Aya;Kurasawa Kazuhiro;Hiyama Tomoka;Komatsu Sara;Kikuchi Azusa;Yoshida Yuhi;Hasegawa Anna;Miyao Tomoyuki;Tanaka Ayae;Arai Satoko;Maezawa Reika;Arima Masafumi;Ikeda Kei, Arthritis research & therapy, 27(1), 89, 16 Apr. 2025